640 related articles for article (PubMed ID: 30453754)
1. A retrospective pilot study to examine the potential of aspartate aminotransferase to alanine aminotransferase ratio as a predictor of postoperative acute kidney injury in patients with hepatocellular carcinoma.
Xu J; Xia Y; Li S; Cheng X; Hu S; Gao Y; Zhou X; Wang G; Zheng Q
Ann Clin Biochem; 2019 May; 56(3):357-366. PubMed ID: 30453754
[TBL] [Abstract][Full Text] [Related]
2. A new plasma biomarker enhance the clinical prediction of postoperative acute kidney injury in patients with hepatocellular carcinoma.
Zhou X; Wang L; Wang G; Cheng X; Hu S; Ke W; Li M; Zhang Y; Song Z; Zheng Q
Clin Chim Acta; 2017 Dec; 475():128-136. PubMed ID: 29031454
[TBL] [Abstract][Full Text] [Related]
3. Does Aspartate Aminotransferase to Alanine Aminotransferase Ratio Predict Acute Kidney Injury After Cardiac Surgery?
Gultekin Y; Bolat A; Hatice K; Tekeli Kunt A
Heart Surg Forum; 2021 Jun; 24(3):E506-E511. PubMed ID: 34173741
[TBL] [Abstract][Full Text] [Related]
4. De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study.
Lee H; Lee SE; Byun SS; Kim HH; Kwak C; Hong SK
BJU Int; 2017 Feb; 119(2):261-267. PubMed ID: 27226065
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of aspartate aminotransferase/alanine aminotransferase ratio in hepatocellular carcinoma after hepatectomy.
Huo RR; Pan LX; Wu PS; Liang XM; You XM; Ma L; Zhong JH
BJS Open; 2024 Jan; 8(1):. PubMed ID: 38242573
[TBL] [Abstract][Full Text] [Related]
6. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
[TBL] [Abstract][Full Text] [Related]
7. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease.
Giannini E; Risso D; Botta F; Chiarbonello B; Fasoli A; Malfatti F; Romagnoli P; Testa E; Ceppa P; Testa R
Arch Intern Med; 2003 Jan; 163(2):218-24. PubMed ID: 12546613
[TBL] [Abstract][Full Text] [Related]
8. Preoperative aspartate transaminase/alanine transaminase ratio as a prognostic biomarker in primary non-muscle-invasive bladder cancer: a propensity score-matched study.
Cheng X; Zhou X; Yi M; Xu S; Zhang C; Wang G
BMC Urol; 2021 Sep; 21(1):136. PubMed ID: 34579695
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of ALT, AST, and AAR in Hepatocellular Carcinoma with B-Type Hepatitis-Associated Cirrhosis after Radical Hepatectomy.
Zhou L; Wang SB; Chen SG; Qu Q; Rui JA
Clin Lab; 2018 Oct; 64(10):1739-1747. PubMed ID: 30336532
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Aspartate Aminotransferase-to-Platelet Ratio Index Predicts Perioperative Liver-Related Complications Following Liver Resection for Colorectal Cancer Metastases.
Amptoulach S; Gross G; Sturesson C; Rissler P; Kalaitzakis E
Scand J Surg; 2017 Dec; 106(4):311-317. PubMed ID: 28737112
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Preoperative Aspartate Transaminase/Alanine Transaminase Ratio as an Independent Predictive Biomarker in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Propensity Score Matching Study.
Ishihara H; Kondo T; Yoshida K; Omae K; Takagi T; Iizuka J; Tanabe K
Clin Genitourin Cancer; 2017 Oct; 15(5):598-604. PubMed ID: 28495053
[TBL] [Abstract][Full Text] [Related]
13. Elevated alanine aminotransferase and low aspartate aminotransferase/alanine aminotransferase ratio are associated with chronic kidney disease among middle-aged women: a cross-sectional study.
Ochiai H; Shirasawa T; Yoshimoto T; Nagahama S; Watanabe A; Sakamoto K; Kokaze A
BMC Nephrol; 2020 Nov; 21(1):471. PubMed ID: 33172399
[TBL] [Abstract][Full Text] [Related]
14. A descriptive analysis of aspartate and alanine aminotransferase rise and fall following acetaminophen overdose.
Curtis RM; Sivilotti ML
Clin Toxicol (Phila); 2015 Nov; 53(9):849-55. PubMed ID: 26294195
[TBL] [Abstract][Full Text] [Related]
15. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity.
Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ;
Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of serum gamma-glutamyltransferase levels and AST/ALT in primary hepatic carcinoma.
Zhang LX; Lv Y; Xu AM; Wang HZ
BMC Cancer; 2019 Aug; 19(1):841. PubMed ID: 31455253
[TBL] [Abstract][Full Text] [Related]
17. Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?
Park GJ; Lin BP; Ngu MC; Jones DB; Katelaris PH
J Gastroenterol Hepatol; 2000 Apr; 15(4):386-90. PubMed ID: 10824882
[TBL] [Abstract][Full Text] [Related]
18. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
[TBL] [Abstract][Full Text] [Related]
19. Loss of Life Expectancy by 10 Years or More From Elevated Aspartate Aminotransferase: Finding Aspartate Aminotransferase a Better Mortality Predictor for All-Cause and Liver-Related than Alanine Aminotransferase.
Xie K; Chen CH; Tsai SP; Lu PJ; Wu H; Zeng Y; Ye Y; Tu H; Wen C; Huang M; Zhang Y; Lee JH; Tsai MK; Wen CP; Wu X
Am J Gastroenterol; 2019 Sep; 114(9):1478-1487. PubMed ID: 31425154
[TBL] [Abstract][Full Text] [Related]
20. Aspartate aminotransferase-to-platelet ratio predicts response to transarterial chemoembolisation and prognosis in hepatocellular carcinoma patients.
Tang T; Qiu JL; Li GW; Huang MP; Li Y; Li YJ; Gu SZ
Clin Radiol; 2018 Mar; 73(3):259-265. PubMed ID: 29032942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]